Cinctive Capital Management LP Purchases Shares of 5,572 The Clorox Company $CLX

Cinctive Capital Management LP purchased a new position in shares of The Clorox Company (NYSE:CLXFree Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,572 shares of the company’s stock, valued at approximately $687,000.

A number of other hedge funds have also recently made changes to their positions in CLX. Invesco Ltd. raised its position in Clorox by 138.3% in the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after purchasing an additional 1,883,465 shares during the period. Norges Bank bought a new stake in Clorox in the second quarter worth $190,429,000. Van ECK Associates Corp boosted its position in Clorox by 93.9% during the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after buying an additional 1,312,471 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in shares of Clorox by 218.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock valued at $149,983,000 after buying an additional 856,873 shares during the last quarter. Finally, Worldquant Millennium Advisors LLC bought a new position in shares of Clorox during the second quarter valued at about $71,856,000. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Up 1.3%

NYSE CLX opened at $112.09 on Tuesday. The business’s 50-day moving average is $115.87 and its 200 day moving average is $113.25. The stock has a market capitalization of $13.55 billion, a PE ratio of 18.32, a PEG ratio of 0.55 and a beta of 0.59. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The Clorox Company has a 1 year low of $96.66 and a 1 year high of $150.84.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter last year, the business posted $1.55 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be issued a $1.24 dividend. The ex-dividend date is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 4.4%. Clorox’s payout ratio is 81.05%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Evercore lowered their target price on Clorox from $132.00 to $115.00 and set an “underperform” rating for the company in a research note on Wednesday, February 4th. Rothschild & Co Redburn set a $117.00 price target on Clorox in a research report on Friday, February 13th. Deutsche Bank Aktiengesellschaft lowered their price objective on Clorox from $114.00 to $112.00 and set a “hold” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, The Goldman Sachs Group cut their target price on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a report on Wednesday, January 7th. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $118.73.

Read Our Latest Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.